You are here: Industry Insights > SARS-CoV-2

News List

Applied Biology and Corpometria Institute to launch anti-androgen clinical study for COVID-19 treatment expresspharma
September 24, 2020
Discovery potentially links SARS-CoV-2 infectivity to androgens, the same hormones implicated in male pattern baldness and prostate cancer.
COVID-19 study links strict social distancing to much lower chance of infection worldpharmanews
September 24, 2020
Using public transportation, visiting a place of worship, or otherwise traveling from the home is associated with a significantly higher likelihood of testing positive with the coronavirus SARS-CoV-2 ...
Just How Reliable Are COVID-19 Tests? Experts Weigh In drugs.xom
September 24, 2020
You're feeling pretty darned sick -- headache, fever, fatigue, a cough -- but your COVID-19 test came back negative.
RedHill Biopharma’s Opaganib Demonstrates Complete Inhibition of SARS-CoV-2 americanpharmaceuticalreview
September 24, 2020
RedHill Biopharma announced opaganib demonstrated potent inhibition of SARS-CoV-2, the virus that causes COVID-19, achieving complete blockage of viral replication in an in vitro model of human lung bronchial tissue.
Vela Diagnostics' SARS-CoV-2 RT-PCR Test v2.0 Authorized for Emergency Use in the U.S. prnasia
September 23, 2020
Vela Diagnostics announced today that the ViroKey™ SARS-CoV-2 RT-PCR Test v2.0 has obtained the Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA).
Contact tracing inside infected cells offer new clues about SARS-CoV-2 virus: Study expresspharma
September 23, 2020
The findings of this research could lead to better diagnostics or new treatments, as well as helping to explain what makes this virus so good at the process of infection.
Statement on AstraZeneca Oxford SARS-CoV-2 Vaccine, AZD1222, COVID-19 Vaccine Trials Temporary Pause drugs.com
September 23, 2020
As part of the ongoing randomised, controlled clinical trials of the AstraZeneca Oxford coronavirus vaccine, AZD1222...
COVID-19 vaccine tablet induces systemic and mucosal immune responses europeanpharmaceuticalreview
September 23, 2020
The researchers suggest inducing a mucosal immune response may be crucial to protect against SARS-CoV-2 infection and that the tablet formulation could overcome several major challenges associated with injectable vaccines.
Ortho Awarded BARDA Contract to Accelerate Antigen Test Development and Additional SARS-CoV-2 Antibody Test Milestones prnasia
September 22, 2020
Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, today announced its continued collaboration with the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and...
Experimental drug blocks COVID-19 viral entry into lung cells expresspharma
September 21, 2020
Researchers at NYU Grossman School of Medicine made changes to a free ACE2 molecule, and then fused one part of it to a piece of an antibody, an immune system protein, with the goal of strengthening its antiviral effect.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 61 62 Next page